Antibiotics and proton pump inhibitors suppress the efficacy of immunotherapy against non‐small cell lung cancer
Main Author: | Xiayao Diao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-07-01
|
Series: | Thoracic Cancer |
Online Access: | https://doi.org/10.1111/1759-7714.13470 |
Similar Items
-
Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non‐small cell lung cancer
by: Osamu Kanai, et al.
Published: (2021-03-01) -
CXCR4 polymeric nanocomplex‐mediated pulmonary delivery of siPD‐L1: A novel procedure to enhance immunotherapy
by: Xiayao Diao
Published: (2020-10-01) -
Efficacy of Proton Pump Inhibitor in Patients with Non-cardiac Chest Pain
by: Sun Hyung Kang
Published: (2020-06-01) -
Evaluation of antimicrobial efficacy of calcium hydroxide along with proton pump inhibitor against Enterococcus faecalis
by: Namitha Divakar, et al.
Published: (2020-01-01) -
Pharmacogenetics of proton pump inhibitors
by: M. V. Leonova
Published: (2015-12-01)